课题基金 / 基金详情

Investigating an immune checkpoint mechanism linked to drug resistance in cancer cells

Investigating an immune checkpoint mechanism linked to drug resistance in cancer cells
研究与癌细胞耐药性相关的免疫检查点机制
批准号：
349841
负责人：
Minassian Lori
金额：
$1.27万
依托单位：
Queen's University (Kingston, Ontario)
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-12-01 至 2016-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=349841&lang=en
关键词：
Autophagy Cancer Immunotherapy Chemoresistance Chemotherapy Drug Resistance Immune Checkpoints Pd-1/Pd-L1

项目摘要

项目成果

Minassian Lori的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Investigating how the immune system can contribute to drug resistance in cancerThere are many barriers to successful cancer treatment, including the ability of cancer cells to resist immune destruction and chemotherapy. Normally, immune cells can recogniz
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of the Programmed Death Ligand 1 (PD-L1) immune checkpoint in the acquisition of malignant phenotypes in tumour cells
Role of the Programmed Death Ligand 1 (PD-L1) immune checkpoint in the acquisition of malignant phenotypes in tumour cells
海外基金